Metabolix (MBLX) Announces that Mirel Bioplastics is Chosen by Labcon for New Laboratory Liquid Handling System

June 30, 2008 5:45 PM EDT

Metabolix (NASDAQ: MBLX) announced that Telles(TM), its joint venture with Archer Daniels Midland Company (NYSE: ADM) that produces Mirel(TM) bioplastics, has entered into an agreement to supply Mirel bioplastic resin to Labcon North America, a leading manufacturer of laboratory supplies, for the production of its new Pagoda pipet reloading system.

"Labcon's product launch demonstrates business equipment as one of our strategic short term applications for which Mirel will be utilized," said Bob Findlen, Vice President of Sales and Marketing, Telles. "This very complicated part demonstrates the versatility and ease with which Mirel can be used for injection molding applications. Until today, bioplastics in general have had limited capability in injection molding applications."

Metabolix is an innovation driven bioscience company focused on providing sustainable solutions for the world's needs for plastics, chemicals and energy.


Related Categories

Corporate News

Stocks Mentioned

ADM 32.26

-0.35 -1.07%
Volume: 3,284,684
Track ADM

MBLX 9.33

-0.54 -5.47%
Volume: 1,677,389
Track MBLX


Add Your Comment